| IMRT spares bladder in prostate radiation
BOSTON, Oct. 11 Intensity modulated radiation therapy, or IMRT, spares the bladder more from direct radiation compared to 3-D conformal proton therapy, a U.S. study found.
The Massachusetts General Hospital Department of Radiation Oncology and Harvard Medical School, both in Boston, jointly conducted the study to determine the comparative benefits and drawbacks of IMRT versus 3D-CPT as treatments for patients with prostate cancer and to determine whether specific cases should be assigned to one treatment method over the other.
"This study was important because it reassures a patient with prostate cancer that the methods that are available at his local hospital may, in many cases, be as good as those that are currently only available in a limited number of centers," study author Dr.
Folk Ways
As for how he came to hold certain views on health care, he has this answer for his audience in Anderson, S.C.: "I had a conversation with my little mama back in Franklin, Tennessee." His 87-year-old mother's advice also persuades him to reject the new National Intelligence Estimate reporting that Iran has suspended its nuclear program. "Remember whatcha mama told ya," the former senator from Tennessee recommends. "If somethin' appears to be too good to be true, it probably is." Is it possible to be too folksy? Thompson seems determined to find out. The big man with all those Hollywood roles is trying to slow-drawl his way to the GOP nomination. To the extent that Thompson has a pitch, it's that he doesn't change his views like, say, Mitt Romney or Rudy Giuliani.
Outside the Top 25: Irish fling
So take your “Notre Dame is 9-1 SU against Air Force in the last 20 seasons" stats and toss ‘em out the window. Charlie Weis has given up on 2007. He went for it on every fourth down situation, even to the team's detriment, and is toying with the idea of a two-quarterback rotation this weekend. Air Force, in the meantime, has a shot at the MWC title. These Falcons don't fly, preferring to pound opponents on the ground, as evidenced by their 437 rushing yards against Army last week. Considering how ineffective the Irish looked against Navy's run, Notre Dame may have to depend on its finale against Duke to avoid a winless '07 campaign at home. Houston at Tulsa (-1, N/A) The C-USA West crown is effectively on the line in Tulsa on Saturday.
Dr R. Vatsyayan
When the surface of a normal eye�s cornea has a spherical curve, like the shape of a basket ball, light rays passing through it bend towards its centre and focus on one spot. Sometimes, the surface of the cornea is curved unevenly, with both flatter and steeper curves. When the surface of the cornea has an uneven curvature, vision becomes distorted. This common irregularity, called corneal astigmatism, causes blurred or distorted vision because light rays are not focused on one spot to provide clear vision. Health Notes Vitamin C �does not protect against the common cold� Link between spondylitis, inflammatory bowel disease Stem cells may harbour cure for heart attack Ancient fears make people dislike the obese .
Photo: Give A Kimmie Cares(TM) Doll This Holiday Season
CINCINNATI, Nov. 15 /PRNewswire/ -- The Kimmie Cares(TM) doll and accompanying book; Mommy and Me...Taking Care of Each Other is a special and thoughtful gift for any child in your life who has a mom or other female relative undergoing treatment for cancer. It helps ease the child's fears and also helps the mother explain cancer therapy and its effects in an uplifting and positive way. To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/kimmiecares/30709/ The holidays are an extremely difficult time for those undergoing treatment for cancer. The normally stressful season can be compounded as the physical and emotional effects caused by both chemotherapy and radiation take their toll. So often those whose lives have been touched by cancer are very uncomfortable talking about it and need help communicating their feelings.
FDA approves trial for SKCC breast cancer vaccine
The Federal Drug Administration announced Friday approval of a Phase 1 clinical trial designed to study a breast cancer vaccine developed at the Sidney Kimmel Cancer Center. According to SKCC President and CEO Dr. Albert Deisseroth, "This vaccine will be administered for recurrent breast cancer and is the first cancer vaccine to be specifically designed for the aged immune system which often fails to respond to vaccinations for infectious diseases as well as cancer." "If the vaccine is able to suppress the growth of established breast cancer, it is very likely that it will be of use in preventing the development of breast cancer in families genetically predisposed to this disease, " said Joy Hamer, RN, OCN and SKCC's Director of Clinical Development and Regulatory Affairs.
Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American ...
This application of Nektar's PEGylation technology to reduce blood-brain barrier penetration of a small molecule drug is ground-breaking. Going forward, we will leverage the ability to use PEGylation technology to manage penetration of the blood-brain barrier with additional, innovative CNS product opportunities." Phase 1 Clinical Study Design and Results This single-dose, double-blind, placebo-controlled study was conducted to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic profile of NKTR-118 in healthy male subjects. The trial measured the morphine-induced delay in GI transit time, a peripheral effect, using the lactulose hydrogen GI motility test. Pupillometry, a measurement of the diameter of the pupil of the eye, was used to monitor antagonism of morphine-induced pupil constriction, a central nervous system (CNS) effect.
Shorter Breast Cancer Treatment Works
Dec. 13, 2007 (San Antonio) -- A more convenient three-week course of radiation works just as well as the five-week schedule that is typically given to women after breast-conserving surgery for breast cancer, researchers report. In a study of more than 1,000 women, only 6.2% of those who got the short course of radiation had cancer recur in the same breast over the next 10 years, compared with 6.7% of those who got the conventional five weeks of radiation. The difference was so small, however, that it could have been due to chance. There was also no difference between the two groups in terms of survival, with 84% of those in both groups alive at 10 years, says researcher Timothy Whelan, MD, of the Hamilton Regional Cancer Center in Ontario, Canada. The two schedules were also associated with a similar, low rate of skin reactions and other side effects, Whelan says.
|
